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Abstract: The ability of a,a-di-n-alkyl glycines with linear and cyclic alkyl side chains to stabilize
helical conformations has been compared using a model heptapeptide sequence. The conformations
of five synthetic heptapeptides (Boc–Val–Ala–Leu–Xxx–Val–Ala–Leu–OMe, Xxx 5 Ac8c, Ac7c, Aib,
Dpg ,and Deg, where Ac8c 5 1-aminocyclooctane-1-carboxylic acid, Ac7c 5 1-aminocycloheptane-
1-carboxylic acid, Aib 5 a-aminoisobutyric acid, Dpg 5 a,a-di-n-propyl glycine, Deg 5 a,a-di-
n-ethyl glycine) have been investigated. In crystals, helical conformations have been demonstrated
by x-ray crystallography for the peptides, R–Val–Ala–Leu–Dpg–Val–Ala–Leu–OMe, (R 5 Boc and
acetyl). Solution conformations of the five peptides have been studied by 1H-nmr. In the apolar
solvent CDCl3, all five peptides favor helical conformations in which the NH groups of residues 3–7
are shielded from the solvent. Successive NiH7 Ni11H nuclear Overhauser effects over the length
of the sequence support a major population of continuous helical conformations. Solvent titration
experiments in mixtures of CDCl3/DMSO provide evidence for solvent-dependent conformational
transitions that are more pronounced for the Deg and Dpg peptides. Solvent-dependent chemical
shift variations and temperature coefficients in DMSO suggest that the conformational distributions
in the Deg/Dpg peptides are distinctly different from the Aib/Acnc peptides in a strongly solvating
medium. Nuclear Overhauser effects provide additional evidence for the population of extended
backbone conformations in the Dpg peptide, while a significant residual population of helical
conformations is still detectable in the isomeric Ac7c peptide in DMSO. © 2000 John Wiley &
Sons, Inc. Biopoly 53: 84–98, 2000
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INTRODUCTION
The introduction of a second alkyl group at the a-car-
bon atom results in a dramatic restriction in the range
of accessible backbone conformations for a, a-di-n-
alkylglycines as compared to the standard protein
amino acids.1,2 a-Aminoisobutyric acid (Aib), a con-
stituent of several membrane-active natural pep-
tides,3–5 is the most extensively investigated member
of the family of a, a-dialkylated residues and has
been shown to be an extremely strong stabilizer of
helical conformations in oligopeptides.2,6–12 Oli-
gopeptides ($7 residues) of nonpolar L-amino acids
(Ala, Leu, Val, Ileu, Phe, Met) are generally poorly
soluble in organic solvents and have a great tendency
to form self-associated structures. Incorporation of
even a single Aib residue promotes intramolecular
helix formation resulting in highly soluble peptides
that dissolve in a variety of nonpolar solvents.13–15
Helix formation in apolar peptides of length 6–9
residues can be achieved by placement of a single Aib
residue at a central position with several examples
being characterized in crystals.7 A model heptapep-
tide, Boc–Val–Ala–Leu–Aib–Val–Ala–Leu–OMe,
has been used in our laboratory as a preformed helical
module in the assembly of synthetic helix–helix mo-
tifs.16,17 Crystal structure determinations of this hep-
tapeptide in different polymorphic forms have re-
vealed evidence for solvated helical backbones and
partially unfolded termini, suggesting that this se-
quence is delicately poised with respect to unfolding
as a function of environmental conditions.18,19 The
potential fragility of this designed helix may be used
to advantage in probing the relative helix-stabilizing
abilities of diverse a, a-dialkyl amino acids. Confor-
mational energy calculations suggest that helical re-
gions of f,c-space are a pronounced energy minima
in the case of Aib1,2 and 1-aminocycloalkane-1-car-
boxylic acids (Acnc),20 whereas in the case of dialky-
lglycines with linear alkyl chains (Dxg), fully ex-
tended structures appear to be marginally lower in
energy than helical conformations.21 The preferred
conformations reported for the Acnc residues parallel
those of the prototype residue Aib.22–25 Nuclear mag-
netic resonance studies showed that tripeptides con-
taining Dxg residues promote extended conformation
in solution, whereas the Acnc residues promote folded
conformation in analogous sequences under identical
conditions.26 In the case of dipropylglycine (Dpg),
both extended27–29 and helical conformations30–32
have been characterized in peptide crystal structures.
Experimental results on Deg-containing peptides sug-
gest that these residues favor fully extended confor-
mation in homooligopeptides.33 In principle, there-
fore, helices formed with Dxg peptides may be more
susceptible to unfolding as compared to Aib- and
Acnc-containing structures. We have chosen to exam-
ine a series of heptapeptides, Boc–Val–Ala–Leu–
Xxx–Val–Ala–Leu–OMe (Xxx 5 Ac8c, Ac7c, Aib,
Dpg, and Deg) in an apolar solvent CDCl3, where
helices are expected to be favored, and in a polar-
solvating medium (CD3)2SO, where unfolded sol-
vated structures can be populated.34 The results dem-
onstrate that the Deg and Dpg peptides have a signif-
icantly greater tendency to unfold in a strongly
interacting solvent. Helical conformations are demon-
strated for two variants of the Dpg heptapeptide in
single crystals by x-ray diffraction.
EXPERIMENTAL PROCEDURES
Synthesis of Amino Acids and Peptides
Ca,a-dialkylated amino acids were synthesized from the
appropriate ketones in good yield and purity by reported
procedures.27,35
The peptides were synthesized by conventional solution
phase procedures using a fragment condensation strategy.
For the Aib and Acnc peptides, fragment couplings could be
achieved in high yield when the Aib/Acnc residues were at
the C-terminus. For the Dxg peptides the unit Leu–Dxg–Val
was extended in both N- and C-terminal directions to over-
come the problem of low coupling yields in fragment con-
densation when Dxg was at the C-terminus. The Boc group
was used for the N-terminal protection and the C-terminus
was protected as a methyl ester. Deprotections were per-
formed using 98% formic acid or saponification, respec-
tively. Coupling reactions in the preparation of dipeptides
were mediated by dicyclohexylcarbodiimide (DCC) in di-
chloromethane (DCM) and all other couplings were carried
out in dimethylformamide (DMF), in the presence of DCC
and 1-hydroxybenzotriazole (HOBt). All the intermediate
peptides were characterized by 1H-nmr (80 MHz) and thin
layer chromatography (TLC), and used without further pu-
rification. The final peptides were purified by medium pres-
sure liquid chromatography on a reversed phase C18 col-
umn. Homogeneity was established by high performance
liquid chromatography (HPLC) on a (4 3 250 mm particle
size 5 m) C18 column using methanol/water gradients. All
final peptides were fully characterized by 500 MHz 1H-nmr
and FAB mass spectrometry. Representative synthetic pro-
cedures for the peptides in the Acnc and Dxg series are
given below. Physical characteristics and mass spectral
characteristics for all the peptides are summarized in Ta-
ble I.
Synthesis of Boc–Val–Ala–Leu–Ac8c–Val–
Ala–Leu–OMe (Ac8c-7)
Boc–Leu–Ac8c–OMe (1). Boc–Leu–OH (2.30g, 10
mmol) was dissolved in dichloromethane (7 mL) and cooled
in an ice bath. H2N–Ac8c–OMe isolated from 3.5 g (16.5
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mmol) of its hydrochloride was added, followed by DCC
(2.06g, 10 mmol) and stirred for 36 h at room temperature.
Dichloromethane was evaporated, the residue was diluted
with ethylacetate, and DCU filtered. The solution was
washed with 2N HCl (3 3 50 mL), brine (3 3 50 mL), 1M
Na2CO3 (3 3 50 mL) and water (50 mL). The organic layer
after drying over anhydrous Na2SO4 and evaporation under
reduced pressure afforded 3.9 g (98%) of a white solid.
1H-nmr ( 80 MHz,CDCl3, d): 0.90, 6H (Leu Cd H3); 1.40,
9H, s (Boc CH3); 1.50, 1.63 17H (Ac8c ring protons, Leu
CbH2/Cg H); 3.65, 3H, s (—O—CH3); 3.95, 1H, m (Leu Ca
H); 4.85, 1H, d (Leu NH); 6.38, 1H, s (Ac8c NH).
Boc–Leu–Ac8c–OH (2). Boc–Leu–Ac8c–OMe (3.58g, 9
mmol) was dissolved in methanol (9 mL) and 4N NaOH (4
mL) was added. The reaction mixture was stirred at room
temperature, and the progress of the reaction monitored by
TLC. After completion of the reaction, methanol was evap-
orated, and the residue taken in water and washed with
ether. The aqueous layer was cooled in an ice bath, and
acidified to pH 2 with 6N HCl and extracted with ethylac-
etate (3 3 50 mL). The organic layer after drying over
anhydrous Na2SO4 and evaporation under reduced pressure
afforded 3.26 g (8.54 mmol, 95%) of a white solid.
Boc–Leu–Ac8c–Val–Ala–Leu–OMe (3): Boc–Leu–
Ac8c–OH, 2.104 g (6 mmol) was coupled to 2.2 g (7 mmol)
of H2N–Val–Ala–Leu–OMe31 using DCC (1.648 g, 8
mmol) and HOBt (810 mg, 6 mmol) in DMF, with stirring
for 5 days at room temperature. The mixture was diluted
with ethylacetate and the DCU filtered. The filtrate was
washed with brine (50 mL), 2N HCl (3 3 50 mL), brine (50
mL), 1M Na2CO3 (3 3 50 mL) and again with brine (50
mL). The organic layer was dried over anhydrous Na2SO4
and evaporated under reduced pressure to afford 3.27 g (4.8
mmol, 80%) of the pentapeptide as a white solid. 1H-nmr
(80 MHz, CDCl3, d): 0.90, 18H (Leu Cd H3, Val CgH3);
1.40, 1.47, 1.63, 24 H (Ala CbH3, Ac8c ring protons, Leu
CbH2, CgH, Val CbH); 1.50, 9H, s (Boc CH3); 3.65, 3H, s
(—O—CH3); 3.95—4.35, 4H, m (Val/Ala/Leu CaH) 4.85,
1H, d (Leu NH); 6.60, 1H, s (Ac8c NH); 6.6–7.6, 3H
(Val/Ala/Leu NH)
H2N–Leu–Ac8c–Val–Ala–Leu–OMe (4). Deprotec-
tion of 3 (2.7 g, 4 mmol) was done using 18 mL of 98%
formic acid for 16 h at room temperature. After completion
of the reaction, excess formic acid was evaporated, the
residue taken in water, and washed with ether (2 3 15 mL).
The pH of the aqueous layer was adjusted to 8 with
Na2CO3. The product was extracted into ethylacetate (3
350 mL). The ethylacetate layer was dried over anhydrous
Na2SO4 evaporated under reduced pressure to afford 1.58 g
(2.72 mmol, 68%) of the free amine as a gum, which was
ninhydrin positive.
Boc–Val–Ala–Leu–Ac8c–Val–Ala–Leu–OMe (5).
Boc–Val–Ala–OH (0.518 g, 1.8 mmol) was coupled to
1.58 g (2.7 mmol) of 4 using DCC (0.515 g, 2.5 mmol) and
HOBt (0.24 g, 1.8 mmol) in DMF by stirring for 6 days at
room temperature. The mixture was diluted with ethylac-
etate and DCU filtered. The filtrate was washed with brine
(50 mL), 2N HCl (3 3 50 mL), brine (50 mL), 1M Na2CO3
(3 3 5 0 mL) and again with brine (50 mL). The organic
layer was dried over anhydrous Na2SO4 and evaporated
under reduced pressure to afford 1.45 g (1.71 mmol, 95%)
of the heptapeptide as a solid.
Synthesis of Boc–Val–Ala–Leu–Dpg–Val–
Ala-Leu-OMe (Dpg-7)
Boc–Leu–Dpg–OMe (6). Boc–Leu–OH (4.6 g, 20
mmol) was dissolved in dichloromethane (8 mL) and cooled
in an ice bath. H2N–Dpg–OMe isolated from (5.25 g, 25
mmol) of its hydrochloride was added, followed by DCC
(4.16 g, 20 mmol) and stirred for 36 h at room temperature.
Dichloromethane was evaporated, the residue was diluted
with ethylacetate, and DCU filtered. The solution was
washed with brine (1 330 mL), 2N HCl (3 3 50 mL), brine
(1 3 30mL), 1M Na2CO3 (3 3 50 mL), and again with
brine (50 mL). The organic layer was dried over anhydrous
Na2SO4 and evaporated under reduced pressure to afford
6.9 g (18 mmol, 94%,) of a white solid. 1H-nmr (80 MHz,
CDCl3, d): 0.80–0.93, 12H (CdH3 Leu/Dpg); 1.26, 1.65,
2,20, 11H (Dpg CbH2/CgH2, Leu CbH2/CgH); 1.42, 9H, s
(Boc CH3); 3.42, 3H, s (—O—CH3); 3.98, 1H, m (Leu
CaH); 4.72, 1H, d (Leu NH); 6.80, 1H, s (Dpg NH).
Boc–Leu–Dpg–OH (7). The dipeptide 6 (6.2 g, 6 mmol)
was saponified using 16 mL of methanol and 4 mL of 4N
NaOH with stirring for 4 days at room temperature. Meth-
anol was evaporated and the residue dissolved in water. The
aqueous solution was washed with ether (2 3 15 mL),
cooled in an ice bath and acidified to pH 2 with 6N HCl. The
product was extracted into ethylacetate (3 3 50 mL). The
ethylacetate layer was dried over anhydrous Na2SO4 and
evaporated under reduced pressure to afford 2.85g (6.8
mmol, 85%) of the dipeptide acid as a white solid.
Table I Physical Characteristics of the Peptides Boc–
Val–Ala–Leu–Xxx–Val–Ala–Leu–OMe
Xxx
2
HPLCa
Retention
Time
(in minutes)
mpb
(in °C)
Mcalcd
(Da)
Mobs c
[M 1 Na]1
(Da)
Ac8c 27.5 223.8 850 873
Ac7c 25.4 210.9 836 859
Aib 15.1 194.8 783 807d
Dpg 25.0 196.7 838 861
Deg 20.4 201.5 810 833
a Solvent gradient 60–95% methanol in 50 min. Column: RP.
C18 (4 3 250 mm particle size 5 m). Flow: 0.8 mL/min.
b Melting points are uncorrected.
c Molecular ion masses in fast atom bombardment mass spectra.
d [M 1 Na]1 determined by matrix-assisted laser desorption/
ionization time of flight mass spectra. MH1 determined by elec-
trospray ionization is 784.
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Boc–Leu–Dpg–Val–OMe (8). The dipeptide acid 7
(2.2g, 6 mmol) was coupled to H2N–Val–OMe isolated
from 1.904 g (12 mmol) of its hydrochloride using DCC
(1.6 g, 8 mmol) and HOBt (0.810 g, 6 mmol) in DMF (5
mL) with stirring for 72 h at room temperature. The reaction
mixture was diluted with ethylacetate and DCU filtered. The
ethylacetate layer was washed with brine (50 mL), 2N HCl
(3 3 30 mL), 1M Na2CO3 (3 3 30 mL) and brine (50 mL).
The organic layer was dried over anhydrous Na2SO4 and
evaporated to dryness under reduced pressure to yield 2.764
g (5.74 mmol, 95%) of a white solid. 1H-nmr (80 MHz,
CDCl3, d): 0.88–1.02, 18H (CdH3 Dpg/Leu, Val Cg H3);
1.53, 9H, s (Boc CH3); 1.26, 1.65,1.70, 2.12, 14H (Dpg
CgH2/CbH2, Leu CbH2/CgH/Val CbH2/ CgH); 3.42, 3H, s
(—O—CH3); 4.05–4.35 2H, m (Leu/Val CaH ); 4.72, 1H,
d (Leu NH); 6.30, 1H, d (Val NH); 7.10, 1H, s (Dpg NH).
Boc–Leu–Dpg–Val–OH (9). The tripeptide 8 (2.425g, 5
mmol) was saponified using 5 mL of methanol and 2 mL of
2N NaOH with stirring for 2 days at room temperature.
Workup of the reaction mixture as described in the case of
2 afforded 2.0 g (4.5 mmol, 95%) of the tripeptide acid as
a white solid.
Boc–Ala–Leu–OMe (10) Boc–Ala–OH (5.67 g, 30
mmol) was coupled to H2N–Leu–OMe isolated from 9.05g
(50 mmol) of its hydrochloride using DCC (6.18 g, 30
mmol) and HOBt (4.05g, 30 mmol) in DMF with stirring for
24 h at room temperature. Work up of the reaction mixture
as described in the case of 1 afforded 9.29 g (98%, 29.4
mmol) of a gummy solid. 1H-nmr (80 MHz, CDCl3, d):
0.90, 6H (CdH3 Leu); 1.47, 3H (Ala CbH3); 1.5, 9H, s (Boc
CH3); 1.60,1.72, 3H (Leu CbH2/CgH); 3.70, 3H, s (—O—
CH3); 4.1–4.4, 2H (CaH Ala/Leu); 5.1, 1H, d (Ala NH);
6.4, 1H, d (Leu NH).
H2N–Ala–Leu–OMe (11). The dipeptide 10 (8.9 g, 29
mmol) was deprotected using 100 mL of 98% formic acid at
room temperature. The progress of the reaction was moni-
tored by TLC. On completion of reaction, formic acid was
evaporated under reduced pressure. The residue was taken
in water (100 mL) and washed with ether (2 3 30 mL). The
pH of the aqueous layer was adjusted to 8 with Na2CO3. The
product was extracted into ethylacetate (3 3 60 mL). The
ethylacetate layer was dried over anhydrous Na2SO4 and
evaporated under reduced pressure to afford 4.7g (22.6
mmol, 78%) of a gum that was ninhydrin positive.
Boc–Leu–Dpg–Val–Ala–Leu–OMe (12). The tripep-
tide acid 9 (1.772 g 4 mmol) was coupled to 8 mmol of 11
using DCC (0.824 g, 4 mmol) and HOBt (0.540 g, 4mmol)
in DMF with stirring for five days at room temperature.
Workup of the reaction mixture as described in the case of
3 afforded 2.484 g (3.6 mmol, 90%) of a white solid.
1H-nmr (80 MHz,CDCl3, d): 0.80–0.98, 24H (CdH3, Dpg/
Leu, CgH3, Val) 1.01, 1.26, 1.52;1.67, 2.02, 18H (Dpg
CbH2/CgH2, Leu CbH2/CgH, Val CbH, Ala CbH3) 1.50 9H,
s (Boc CH3); 3.63, 3H, s (—O—CH3); 3.98, 4.12, 4H, m
(Ala/Leu/Val CaH); 4.85, 1H, d (Leu [1] NH); 6.68, 1H, s
(Dpg NH); 6.7–7.6, 3H (Val/Ala/Leu/NH).
H2N–Leu–Dpg–Val–Ala–Leu–OMe (13). Deprotec-
tion of 12 (2.007 g, 3 mmol) was done using 12 mL of 98%
formic acid for 12 h at room temperature. Workup of the
reaction mixture as described in the case of 4 afforded
1.194g (2.1 mmol, 70%) of the free amine as a gum which
was ninhydrin positive.
Boc–Val–Ala–Leu–Dpg–Val–Ala–Leu–OMe (14).
Boc–Val–Ala–OH (0.432 g, 1.5mmol) was coupled to 1.194
g (2.1 mmol) of 13 using DCC (0.39g , 1.5 mmol) and
HOBt (0.025 g, 1.5 mmol) in DMF with stirring for seven
days at room temperature. Work up of the reaction mixture
as described in the case of 3 afforded 1.157 g (1.38 mmol,
92%) of the heptapeptide as a solid.
Acetylation of Peptides
(Ac–Val–Ala–Leu–Xxx–Val–Ala–Leu–OMe;
Xxx 5 Ac8c, Ac7c, Aib, Dpg, Deg)
Acetyl derivatives were prepared for all the five peptides in
order to facilitate acid induced unfolding studies in organic
solvents and to explore crystallization . The general proce-
dure used is given below. The peptide (0.25 mmol) was
deprotected using 98% formic acid. The progress of the
reaction was monitored by TLC. After completion of the
reaction, formic acid was evaporated, the residue was taken
in water, and washed with ether (2 3 20 mL). The aqueous
layer was cooled in an ice bath and neutralized by Na2CO3.
The free base was extracted in ethylacetate (3 3 50 mL),
dried over anhydrous Na2SO4, and concentrated under re-
duced pressure to give the free base as a gum that was
ninhydrin positive. This was dissolved in a 1:1 mixture of
acetic acid and acetic anhydride and stirred overnight at
room temperature. Water (5 mL) was added and the solution
evaporated to dryness. The residue was dissolved in ethyl-
acetate (30 mL) and the solution washed with brine (15
mL), 1N HCl (3 3 15 mL), 1M Na2CO3 (3 3 15 mL), brine
(15 mL), dried over anhydrous Na2SO4 and concentrated
under reduced pressure. Trituration with n-hexane gave a
nice solid. The yields and melting points are as follows:
Ac-Ac8c-7: 72%, Ac-Ac7c-7: 58%, 197°C; 204°C; Ac-
Aib-7: 64%, 184°C; Ac-Dpg-7: 68%, 195°C; Ac-Deg-7:
60%, 192°C.
Spectroscopic Studies
All nmr experiments were carried out on Bruker AMX-400
and DRX-500 spectrometers at the Sophisticated Instrumen-
tation Facility, Indian Institute of Science, Bangalore. All
nmr spectra were recorded at a peptide concentration of 3
mM in both CDCl3 and DMSO. All two-dimensional (2D)
data were acquired at 1K data points, 512 experiments, with
48–64 transients. A 300 ms mixing time was used for
ROESY experiments. The spectral width for all the exper-
iments was set to 4500 Hz. Nuclear magnetic resonance data
were processed using XWINNMR software. All two dimen-
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sional data sets were zero filled to 1024 points with a 90°
phase-shifted squared sine-bell filter in both dimensions.
The probe temperature was maintained at 300 K.
Crystallization and X-Ray Diffraction
Crystals for both Dpg-7 and Ac-Dpg-7 grew as thin plates
with many small inclusions. Crystals for Ac-Dpg-7, and to
a smaller extent for Dpg-7 were in the form of very thin,
fragile wafers that adhered to each other tenaciously. The
crystals used for data collection were most likely a com-
posite of several individual wafers that were sufficiently
well aligned to give a reasonable sharp optical extinction
under crossed Nicol prisms. However, the profiles of the
diffraction spots showed peaks with multiple maxima.
These defects in the single “crystals” available for data
collection contributed to the poor values for the crystallo-
graphic R-factors.
The x-ray diffraction data were measured on a Siemens
P4 automated four-circle diffractometer (presently called
Bruker) equipped with a graphite monochromator. For both
crystals CuKa radiation (l 5 1.54178 Å) was used with a
u/2u scan, a scan width of 2.0° 1 2u (a1-a2) and a scan
speed of 10 deg/min. Three check reflections were read after
every 97 measurements. The standards remained constant
within 3%. Crystal and diffraction parameters are listed in
Table II.
The structure of A-Dpg-7 was solved routinely by
direct phasing methods, while the Dpg-7 structure re-
quired 1000 trials of direct phasing in the TREF routine
found in the SHELXTL package of programs.36 Full-
matrix least-squares refinements with anisopropic ther-
mal parameters were performed on the coordinates of C,
N, and O atoms. Hydrogen atoms were placed in ideal-
ized positions and allowed to ride with the C or N atoms
to which each is bonded. The side chains for Leu and Val
residues had considerable positional motion, especially
near the C-terminals, as evidenced by large values for the
thermal factors for atoms in the side chains. The imper-
fect crystals may have enhanced this effect; however, in
view of the conformational fragility observed in the
model heptapeptide Boc–Val–Ala–Leu–Aib–Val–Ala–
Leu (Aib-7),18,19 where Aib is replaced by Dpg in the
present compounds, the large thermal parameters were
not unexpected. For the least-squares refinement, re-
straints were placed on distances in the Leu (7) side chain
in both Dpg-7 and Ac-Dpg-7, as well as on the Val(5)
side chain in Ac-Dpg-7. Initially, least-squares refine-
ments using F data with uFu . 4s were used, followed by
refinements with F2 data using all the observed data.
There was no significant difference in the results. The
results from the F2 refinement are reported.
Fractional coordinates for Dpg-7 and Ac-Dpg-7 are de-
posited in the Cambridge Crystallographic Data Base.
Table II Crystal and Diffraction Parametersa
Dpg-7 Ac-Dpg-7
Empirical formula C42H76N7O11H2O C39H70N7O9
Crystallizing solvent CH3OH/H2O CH3OH/H2O
Cocrystallized solvent H2O
Color/habit Colorless thin plate Very thin, fragile colorless wafers
Crystal size (mm) 0.12 3 0.25 3 0.55 0.13 3 0.18 3 0.55
Space group P21 21 21 P21
a (Å) 12.138(3) 10.705(3)
b (Å) 16.015(1) 17.567(7)
c (Å) 27.112(3) 13.584(4)
b (deg) 90.0 112.98
V (Å3) 5270 2351.8
Z 4 2
Mol. wt. 855.1 781.0
Density (calc; g/cm3) 1.078 1.103
F(000) 1860 850
T (8C) 21 21
No. of unique reflections 4534 3575
No. of obs. rflns., uF0u . 4sF 2349 2154
Final R1 (obs. data; %) 9.13 15.6
S 1.02 1.05
Resolution (Å) 0.9 0.9
Data/param. ratio 4.2:1.0 4.3:1.0
No. of param. 561 496
a For both crystals, CuKa radiation (l 5 1.54178 Å) was used with a u/2u scan, a scan width of 2.0° 1 2u(a1 2 a2), and a scan speed
of 10 deg/min. Standard reflections were read after every 97 measurements. Standards remained constant (within 3%).
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RESULTS AND DISCUSSION
Crystal State Conformations
Crystal structures determined for the Boc and acetyl
derivatives of the Dpg heptapeptide (Dpg-7 and Ac-
Dpg-7).are shown in Figures 1 and 2, each displaying
two views of the molecular conformations. Although
both peptides adopt helical structures, the Boc ana-
logue adopts a 310-helix with 43 1 hydrogen bonds,
except for some unwinding at the C-terminus, while
the Ac analogue forms a good a-helix. It is notewor-
thy that Aib-7A18 is almost identical to Ac-Dpg-7,
rather than to Dpg-7. A superposition of Aib-7A and
Ac-Dpg-7, made with a least-squares fit of backbone
atoms from N1 to C6a, shows an excellent fit between
the two molecules from the N-terminus (despite hav-
ing an Ac group in one and a Boc group in the other)
to C6a (Figure 3), and despite the high R factor for
Ac-Dpg-7. Differences occur at the C-terminus, but
they are not sufficient to disturb the N7—O3 hydro-
gen bond (a-helical) at 2.92 Å for Ac-Dpg-7 and 3.02
Å for Aib-7A. Backbone torsion angles and hydro-
gen-bond parameters are summarized in Tables III
and IV, respectively.
The facile transition between a 310-helix in the
backbone of Dpg-7 and an a-helix in the backbone of
Ac-Dpg-7, both crystallized from the same solvent
and both having the same sequence, except for the
N-terminal end groups, is indicative of both having
similar conformational energies. The different helix
forms for the backbone cannot be attributed to the
change in end group from Boc to Ac. Pairs of ana-
logues in which the N-terminus has been changed but
in which the conformation remains the same are, for
example, as follows: (Boc)-Aib-7A18,19 and Ac-
Dpg-7 (this paper) wherein Dpg(4) replaces Aib(4) as
well as Ac replaces Boc; and the pair Ac(Aib–Val–
FIGURE 1 Views of the 310-helix adopted by (Boc)-
Dpg-7. The left view is directed perpendicularly to the helix
axis. Dashed lines indicate the NH. . .O hydrogen bonds. A
water molecule W1 forms hydrogen bonds with carbonyl
O5 and carbonyl O7 at the partially unwound C-terminus.
The right view, directed into the interior of the helix, shows
the characteristic triangular projection of a 310-helix back-
bone.
FIGURE 2 Views of the a-helix adopted by Ac-Dpg-7. In
the left view, dashed lines indicate the NH. . .O hydrogen
bonds. The right view, directed into the interior of the helix,
shows a square projection for the backbone segment C2a to
C7a, characteristic of an a-helix.
FIGURE 3 Superposition of the a-helical conformations
of Ac-Dpg-7 (this paper; solid line) and Aib-7A.18 The
differences in the heptapeptide analogues are Ac/Boc and
Dpg4/Aib4 in Ac-Dpg-7 and Aib-7A, respectively.
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Ala–Leu)2OMe and Boc(Aib–Val–Ala–Leu)2OMe37
with different crystal packing but the same conforma-
tion for the molecules. The factors causing the con-
formational fragility in the heptapeptides containing
one Aib or Dpg residue at position 4, that is, helix
transitions, water insertion and unfolding of the back-
bone,18,19 shown in Figure 4, are not yet adequately
defined.
The solid state structures demonstrate that a single
centrally located Dpg residue stabilizes fully helical
conformations in a manner entirely analogous to the
case of Aib residue. Despite the possibility of fully
extended conformation at Dpg, very few examples of
Dpg in nonhelical conformations have so far been
observed in crystal structures of heteromeric peptide
sequences.29,31
NMR Assignments
Sequence specific 1H-nmr assignments were readily
achieved for all the five peptides using a combination
of 2D correlated spectroscopy (COSY) and rotating
frame nuclear Overhauser effect spectroscopy
(ROESY) experiments. The relevant chemical shifts
of the backbone NH and CaH protons for the peptides
in CDCl3 and (CD3)2SO are summarized in Table V.
Table III Torsion Angles (degrees)a
Residue Angle Dpg-7 Ac-Dpg-7 Aib-7A18 Aib-7B18
Aib-719
(DMSO/i-PrOH)
Val(1) f 260 261 271 270 275
c 230 253 241 245 236
v 2176 180 2178 2172 177
x1 2175 178 2179 178 179
275 265 257 261 256
Ala(2) f 272 255 261 265 276
c 22 243 245 245 244
v 170 180 179 179 2179
Leu(3) f 257 262 271 268 262
c 222 248 235 238 229
v 179 2176 180 2177 2179
x1 278 2175 2169 2176 2151,279
x2 259 68 61 57 2178,55
180 2169 2176 2177 253,2175
Xxx(4) f 252 252 257 256 259
c 229 239 235 240 228
v 2175 2176 2178 2173 2176
x1 2170b, 52c 2173, 61c
x2 2176, 177 164, 2173
Val(5) f 271 280 287 291 2109
c 27 227 211 2 17
v 178 2179 173 179 2180
x1 71 274 64 67 60
256 161 261 258 263
Ala(6) f 289 290 278 273 2102
c 1 256 241 236 153
v 180 2169 2175 2177 169
Leu(7) f 265 2145 2127 2134 286
c 153 150 10 222 159
v 172 179 176 2178 176
x1 276 282 267 265 263
x2 180 2173 171 174 174
267 245 262 263 265
a Torsion angles follow the IUPAC-IUB Commission on Biochemical Nomenclature.46 The last 3 columns list values determined earlier
for the peptide Boc–Val–Ala–Leu–Aib–Val–Ala–Leu–OMe (Aib-7) in polymorphic forms. Aib-7A/Aib-7B refers to two molecules in the
asymmetric unit of a P21 cell.
b One propyl side chain is disordered with the other conformation having x1 5 66 and x2 5 170.
c Other propyl side chain.
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Inspection of the chemical shifts reveals that all five
peptides have an extremely similar distribution of NH
and CaH chemical shifts in CDCl3, suggesting close
identity of the backbone conformations in this sol-
vent. In contrast, in (CD3)2SO, the observed pattern of
chemical shifts is very similar for the Ac8c, Ac7c, and
Aib peptides, while marked differences are observed
for the Dpg and Deg peptides. Particularly noteworthy
are the large downfield shifts of the Leu(3) and Val(5)
NH resonances in the Dpg and Deg peptides and the
upfield shift of the Xxx(4) NH. A small but significant
upfield shift is also noted for the Leu (3) CaH reso-
nance in the Dpg and Deg peptides.
Delineation of Solvent-Shielded
NH Groups
Figure 5 shows the effect of addition of a hydrogen-
bonding solvent DMSO to solutions of peptides in an
apolar solvent CDCl3. At low concentrations (;20%
v/v) of the perturbant DMSO, only the Val(1) and
Ala(2) NH groups show appreciable downfield shifts
in the four peptides studied. (Ac8c-7, Ac7c-7, Dpg-7,
and Deg-7). Similar results have earlier been obtained
for the Aib analogue.19 At higher DMSO concentra-
tion, significant differences are observed between the
Acnc peptides on the one hand and the Dxg peptides
on the other. In the case of the Dxg peptides, Leu(3)
NH, Val(5) NH, and Leu(7) NH also show apprecia-
ble downfield shifts with increase in DMSO concen-
tration. The discontinuous solvent titration curves ob-
served for the Dxg analogues is strongly suggestive of
a solvent-dependent conformational transition. At low
DMSO concentrations, largely helical structures are
populated in which only two NH groups Val(1) and
Ala(2) are available for solute–solvent hydrogen
bonding. Beyond a DMSO concentration of 20%, a
significant population of unfolded structures is ob-
tained in the case of the Dxg analogues, rationalizing
the increased exposure of the Leu(3), Val(5) ,and
Leu(7) NH groups. Careful examination of the curves
in Figure 5 reveals that helix fragility in DMSO may
also be a feature in the case of the Acnc analogues,
although the effects are much less pronounced than in
the Dxg peptides.
Solvent shielding of NH groups in DMSO was
probed by measuring the temperature coefficients (dd/
dt) of NH chemical shifts. Since DMSO interacts
strongly with exposed NH groups, higher temperature
coefficients are expected for free NH groups in pep-
tides, while intramolecularly hydrogen-bonded NH
groups exhibit low temperature coefficients. While
quantitative interpretation of dd/dt magnitudes is
risky, nevertheless wide variations in dd/dt values
within the same peptide afford a delineation of ex-
posed and buried NH groups. Figure 6 provides the
comparison of the dd/dt values observed in the five
peptides. The solvent-dependent chemical shift [Dd
Table IV Hydrogen Bonds
Dpg-7 Ac-Dpg-7
Type Donor Acceptor
N. . .O
(Å) Type Donor Acceptor
N. . .O
(Å)
Head to
tail N1 O5 2.99
Head to
tail N1 O4 2.98
Head to
tail N2 W1 2.93
Head to
tail N2 O5 2.96
4 3 1 N3 O0 3.15 N3 O0 3.18a
4 3 1 N4 O1 3.22 5 3 1 N4 O0 2.94
4 3 1 N5 O2 3.05 5 3 1 N5 O1 3.27
4 3 1 N6 O3 2.95 5 3 1 N6 O2 3.17
4 3 1 N7 O4 3.27 5 3 1 N7 O3 2.92
Solvent–
peptide W1 O5 2.75
Solvent–
peptide W1 O7 2.81
a N(3)H. . .O0 5 2.76 Å, too long for a good hydrogen bond.
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5 d(CD3)2SO 2 dCDCl3], which is also a measure of
the degree of solvent exposure, is summarized in
Figure 7. The dd/dt values clearly reveal important
differences between the peptides. The relatively high
dd/dt values observed in DMSO for most of the NH
resonances suggest that fully folded helical conforma-
tions are poorly populated in this strongly interacting
solvent. This is unsurprising since DMSO acts as a
strong hydrogen-bond acceptor and competes for pep-
tide NH groups. Particularly noteworthy are the dd/dt
values observed for the Xxx(4) and Val(5) NH
groups. In the case of the Aib and Acnc peptides, a
low dd/dt value (1.2–1.5 ppb/K) is observed for
Val(5) NH, while a relatively high value (4.8–5.5
ppb/K) is observed for the Xxx(4) NH. In sharp
contrast, exactly the opposite is observed for the Dxg
FIGURE 4 Comparison of conformations for five analogues of (Ac/Boc)–Val–Ala–Leu–(Dpg/
Aib)–Val–Ala–Leu–OMe. (a) A 310-helix with a water molecule insertion into the backbone near
the C-terminus. (b) and (c) a-Helices with two changes of residues between them. (d) a-Helix with
water insertion into backbone [occurring in same crystal as (c)].18 The water insertion is in a
different place than in analogue (a). (e) Distorted and frayed helix crystallized from DMSO/
isopropanol solution. DMSO did not cocrystallize, but two molecules of IprOH and one water
molecule did make hydrogen bonds with backbone atoms.19
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peptides, with Xxx(4) NH having a low dd/dt value
(2.4– 2.5 ppb/K), whereas Val(5) has a very high
dd/dt value (8.2 ppb/K).
A possible interpretation for this observation is that
the Leu(3)–Xxx(4) b-turn conformation remains
highly populated in DMSO for the Aib and Acnc
peptides. This would result in strong solvent shielding
of the Val(5) NH, which would be involved in an
intramolecular 4 3 1 hydrogen bond. Type III
b-turns indeed correspond to isolated 310-helical turns
and have been commonly observed in Aib2,39 and
Acnc peptides.20,22,39,40 The high dd/dt value for Val
(5) NH in the Dxg peptides clearly argues against
such structures. The low dd/dt value for the Xxx(4)
NH may be a consequence of a population of fully
extended C5 structures at the Dxg residue. It should be
noted that in these fully extended conformations, the
Xxx(4) NH group is proximal to the Xxx(4) CO
group, a feature that should result in inhibition of
solvation by DMSO as a consequence of stereoelec-
tronic factors. The approach of the sulfoxide would be
energetically repulsive in the vicinity of the CO
group.34
The Dd values summarized in Figure 7 are more
complicated to interpret since the nature of the major
conformers is dramatically altered on going from
CDCl3 to DMSO. Nevertheless, the distribution of Dd
values across the length of the peptide chain clearly
allows grouping of the peptides into two classes. The
Aib and Acnc analogues belong to one family, while
the Dxg analogues belong to a second family. The
classification is most clearly manifested in the behav-
ior of the Leu(3), Xxx(4), and Val(5) NH groups.
In the case of the Aib and the Acnc analogues,
Val(5) has a very low Dd value, whereas in the Dxg
series this resonance shows a large downfield shift on
going from CDCl3 to DMSO. The situation is re-
versed in the case of the Xxx(4) NH where a moderate
Dd value (;0.6 ppm) is noted for the Aib and Acnc
analogues, while a significantly lower value of ;0.3
ppm is observed for the Dxg peptides. Such a differ-
entiation is also observed for the Leu(3) NH, with the
Dxg peptides showing a much larger solvent shift than
the Aib/Acnc analogues, although in all cases a rela-
tively high value of Dd is observed.
The nmr data described thus far suggest that in an
apolar solvent like CDCl3, all five peptides adopt
predominantly helical conformations with the NH
groups of residues 3–7 being involved in intramolec-
ular hydrogen bonds. The only nonhydrogen-bonded
NH groups are those of Val(1) and Ala(2). Both 310-
and mixed 310/a-helical structures involving bifur-
Table V NMR Parameters for the Peptides Boc–Val–Ala–Leu–Xxx–Val–Ala–Leu–OMe
Chemical Shifts in CDCl3 (d, ppm)
Xxx 3
Residue
2
NH CaH
Ac8c Ac7c Aib Dpg Deg Ac8c Ac7c Aib Dpg Deg
Val(1) 5.44 5.39 5.34 5.32 5.21 3.72 3.72 3.77 3.72 3.73
Ala(2) 6.83 6.85 6.78 6.76 6.70 4.18 4.15 4.16 4.15 4.19
Leu(3) 7.27 7.31 7.30 7.28 7.27 4.19 4.11 4.09 4.12 4.13
Xxx(4) 7.24 7.26 7.49 7.27 7.22 — — — — —
Val(5) 6.75 6.84 6.87 6.77 6.75 4.20 4.18 4.19 4.19 4.21
Ala(6) 7.62 7.57 7.65 7.74 7.72 4.55 4.49 4.50 4.47 4.51
Leu(7) 7.20 7.23 7.27 7.21 7.17 4.56 4.56 4.56 4.52 4.55
Chemical Shifts in (CD3)2SO (d, ppm)
Xxx 3
Residue
2
NH CaH
Ac8c Ac7c Aib Dpg Deg Ac8c Ac7c Aib Dpg Deg
Val(1) 6.77 6.75 6.76 6.73 6.73 3.79 3.78 3.78 3.77 3.78
Ala(2) 7.93 7.92 8.00 7.86 7.85 4.26 4.27 4.26 4.33 4.35
Leu(3) 7.95 7.97 7.91 8.32 8.35 4.29 4.29 4.29 4.06 4.10
Xxx(4) 7.84 7.85 8.08 7.57 7.54 — — — — —
Val(5) 6.99 6.94 7.07 7.66 7.66 4.04 4.04 4.05 4.05 4.07
Ala(6) 7.84 7.78 7.98 7.89 7.92 4.22 4.25 4.25 4.27 4.28
Leu(7) 7.88 8.11 8.10 7.90 7.87 4.25 4.26 4.26 4.26 4.24
Helix-Stabilizing Effects of a,a-Dialkyl Glycines 93
cated hydrogen bonds at the N-terminus are consistent
with the nmr data. Inspection of the crystal structure
of the Dpg containing heptapeptides [Figures 1 and 2
and Tables 3 and 4] reveal that the NH groups of
residues 3–7 are indeed involved in intramolecular
hydrogen bonding. It is therefore reasonable to con-
clude that the predominant conformation in a nonin-
teracting solvent like CDCl3 resembles the structure
observed in crystals. Most notably, all five peptides
show similar solution properties in CDCl3, suggesting
that the nature of the Xxx(4) residue does not signif-
icantly affect the conformational distribution. CD
spectra recorded for all five peptides in methanol were
also largely similar (data not shown), exhibiting a
weak negative band at ;220 nm and a strong negative
band at ;205 nm, a feature of short helical peptides.41
In a strongly solvating medium like DMSO, which
can compete with peptide carbonyl groups for hydro-
gen bonding to NH groups, the situation appears dis-
tinctly different. In DMSO, the observed nmr param-
FIGURE 5 Solvent dependence of NH chemical shifts for the peptides Boc–Val–Ala–Leu–Xxx–
Val–Ala–Leu–OMe in CDCl3–(CD3)2SO mixtures at varying composition [Xxx 5 (a) Ac7c, (b)
Dpg, (c) Ac8c and (d) Deg].
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eters clearly point to differences in the behavior of the
Dxg and Aib/Acnc containing peptides. The stereo-
chemical influence of the amino acids with cycloal-
kane side chains appears to be similar to the prototype
residue Aib. In contrast, residues with linear alkyl side
chains, Dxg, lead to a different conformational distri-
bution resulting in distinctive chemical shift and tem-
perature coefficient patterns. The nmr data suggests
that in all the five peptides the degree of solvent
exposure of NH groups of residues 3 – 7 is clearly
greater than in the case of CDCl3. This is consistent
with the greater fragility of the peptide helix in a
strongly solvating environment.19,34 While the data
supports residual helical conformations, in the case of
the Aib and Acnc peptides, the Dxg analogues may in
fact favor more extended conformations.
Nuclear Overhauser Effects
Interresidue nuclear Overhauser effects (NOEs) be-
tween backbone protons (CaH, NH) can provide a
useful diagnostic for the nature of the distribution of
backbone conformation in solution.42 Observation of
a series of NiH to Ni11H (dNN) NOEs and the absence
of intense CaH to Ni11H (daN) NOEs is a clear
indicator for a predominance of helical conforma-
tions. Conversely, the absence of strong dNN NOEs
and the presence of intense daN NOEs are suggestive
of extended conformations, with c values of 120
6 60. In small peptides, heterogeneity of conforma-
tions in solution is a common occurrence, with the
result that most often dNN and daN NOEs of moderate
intensity are simultaneously observed. Such a feature
is interpreted as indicative of the coexistence of both
helical and extended forms. NOEs were determined
for the Ac7c and Dpg peptides in both CDCl3 and
DMSO. ROESY experiments were used to avoid the
problem of vanishingly small NOEs in the vtc ; 1
region.43 In CDCl3, all the sequential dNN connectivi-
ties were clearly detected over the entire length of the
sequence in both Ac7c and Dpg peptides. Most daN
NOEs were absent or very weak. Thus, the presence
of a population of predominantly helical conforma-
tions for both the Dpg and Ac7c peptides is confirmed.
In DMSO, sequential dNN and daN NOEs were
observed over the entire length of the sequence for
both the peptides supporting mixed conformer popu-
lations. Inspection of the ROESY spectra suggests
that daN NOEs are more intense than dNN NOEs in the
case of the Dpg peptide as compared to the Ac7c
peptide. This is suggestive of a greater population of
extended conformations in the case of the Dpg ana-
logue. Helical conformations in peptides also bring
into proximity backbone protons of residues that are
not adjacent in the sequence. NOEs of the type CiaH
7 Ni12H may also be observed. In ideal 310- and
a-helical conformations the daN (i, i 1 2) distances
are 3.8 and 4.4 Å, respectively.42 Figure 8 shows a
partial ROESY spectrum for the Ac7c peptide in
DMSO, which clearly illustrates the observation of
Leu(3) CaH 7 Val(5) NH NOE, arguing for a sub-
FIGURE 7 Bar diagram showing the solvent induced
perturbation of NH chemical shifts for the peptides Boc–
Val–Ala–Leu–Xxx–Val–Ala–Leu–OMe (Xxx 5 Ac8c,
Ac7c, Dpg, and Deg). Dd 5 d(CD3)2SO 2 dCDCl3.
FIGURE 6 Bar diagram showing the temperature induced
perturbation of NH chemical shifts for the peptides Boc–
Val–Ala–Leu–Xxx–Val–Ala–Leu–-OMe (Xxx 5 Ac8c,
Ac7c, Dpg and Deg). The dd/dt is the temperature coeffi-
cient in (CD3)2SO.
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stantial population of local helical conformations at
the Ac7c(4) residue. A second medium-range NOE,
V(5) CaH7 Leu(7) NH is also detected. In contrast,
these NOEs are not observed in the case of the Dpg
peptide (Figure 9). The NOE results provide further
support for a greater population of helical conforma-
tions in the case of the Ac7c peptide as compared to
the Dpg peptide. Since NOEs are normally observed
only to distances of #4.0 Å in small peptides, the
observation of the daN(i, i 1 2) NOEs is suggestive of
a-helical conformations in the Ac7c peptide. Transi-
tions between 310- and a-helical conformations have
indeed been postulated in short Aib-containing pep-
tides on going from CDCl3 to DMSO.12,44,45
The results of the present study establish that a,a-
dialkylated amino acids bearing linear and cyclic hy-
drocarbon side chains can stabilize helical conforma-
tions in short peptides in apolar solvents like CDCl3.
Although theoretical calculations suggest that fully
extended conformations may be slightly lower in en-
ergy than helical conformations for an isolated Dxg
residue, crystal structures of the two derivatives of a
heptapeptide sequence containing a single Dpg resi-
due reveal helical conformations in both cases.
Clearly, intramolecular hydrogen-bond formation in
helical conformations may tilt the balance in favor of
helical f,c values in Dxg peptides in apolar solvents.
In crystals, facile packing of peptide helices may also
provide a further means of conformational selection.
In a strongly solvating medium like DMSO, however,
the evidence presented in this paper suggests that
helices are more favored in the case of Aib and Acnc
peptides, while nonhelical, extended forms are more
populated in the Dxg-containing sequences. Thus,
helices containing Dxg residues may be more suscep-
tible to unfolding in media that can provide competing
hydrogen-bonding interactions.
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FIGURE 8 Partial 500 MHz ROESY spectrum of Boc–Val–Ala–Leu–Ac7c–Val–Ala–Leu–OMe
in (CD3)2SO showing CaH 7 NH NOEs (X 5 Ac7c).
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